Role of immunoncology in lung cancer treatment

Immunotherapy in lung cancer

Important recent developments in oncology

EGFR and ALK mutations in NSCLC

Sequencing the mesothelioma genom

The proper treatment algorithm for non-oncogene driven NSCLC

Phase 2 trial of nivolumab in NSCLC

Multidisciplinary approach in lung cancer treatment

Immunotherapy as first-line treatment for NSCLC

LBA2_PR - EGFR mutation testing and oncologist treatment choice in advanced NSCLC

Role of checkpoint inhibitors in lung cancer treatment

Targeted therapy in lung cancer

The Lung Cancer Master Protocol

Surgical perspective of lung cancer treatment